Feng Lin

2.7k total citations
75 papers, 2.0k citations indexed

About

Feng Lin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Feng Lin has authored 75 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 29 papers in Oncology and 14 papers in Surgery. Recurrent topics in Feng Lin's work include Sarcoma Diagnosis and Treatment (11 papers), Lung Cancer Treatments and Mutations (10 papers) and Gastric Cancer Management and Outcomes (8 papers). Feng Lin is often cited by papers focused on Sarcoma Diagnosis and Treatment (11 papers), Lung Cancer Treatments and Mutations (10 papers) and Gastric Cancer Management and Outcomes (8 papers). Feng Lin collaborates with scholars based in China, United States and Rwanda. Feng Lin's co-authors include Yang Yao, Lina Tang, Zan Shen, Wei‐Xiang Qi, Aina He, Yuanjue Sun, Daliu Min, Yan Liang, Zaixing Yang and Renqian Zhong and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Feng Lin

70 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng Lin China 27 647 605 600 318 277 75 2.0k
Rajesh Malik United States 23 629 1.0× 648 1.1× 959 1.6× 193 0.6× 174 0.6× 88 2.3k
Jacques‐Olivier Bay France 25 721 1.1× 702 1.2× 538 0.9× 244 0.8× 148 0.5× 151 2.4k
Prasad Mathew United States 28 501 0.8× 587 1.0× 371 0.6× 137 0.4× 272 1.0× 90 3.0k
Jannie Marie Bülow Sand Denmark 22 241 0.4× 451 0.7× 675 1.1× 236 0.7× 325 1.2× 65 1.9k
Zhen Zeng China 24 624 1.0× 419 0.7× 363 0.6× 220 0.7× 341 1.2× 77 2.2k
Yang Yao China 29 1.2k 1.8× 694 1.1× 1.1k 1.8× 302 0.9× 107 0.4× 125 2.4k
Adam Dziki Poland 23 733 1.1× 478 0.8× 333 0.6× 245 0.8× 174 0.6× 188 1.9k
Bhupinder Mann United Kingdom 18 528 0.8× 1.2k 1.9× 337 0.6× 135 0.4× 156 0.6× 43 2.2k
Kellie R. Machlus United States 26 421 0.7× 673 1.1× 562 0.9× 148 0.5× 204 0.7× 70 3.0k

Countries citing papers authored by Feng Lin

Since Specialization
Citations

This map shows the geographic impact of Feng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Lin more than expected).

Fields of papers citing papers by Feng Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Lin. The network helps show where Feng Lin may publish in the future.

Co-authorship network of co-authors of Feng Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Lin. A scholar is included among the top collaborators of Feng Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Lin. Feng Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Chunhua, Xiaojun Lian, Rongrong Wang, et al.. (2024). Gonadal transcriptome analysis of Opsariichthys bidens reveals sex-associated genes. Comparative Biochemistry and Physiology Part D Genomics and Proteomics. 54. 101379–101379. 1 indexed citations
2.
Zhang, Chun, et al.. (2023). Transverse mesocolic hernia with intestinal obstruction as a rare cause of acute abdomen in adults: A case report. World Journal of Clinical Cases. 11(27). 6613–6617. 1 indexed citations
3.
Mu, Ning, et al.. (2020). Characteristics of serum chemokine profile in primary biliary cholangitis. Cytokine. 136. 155291–155291. 6 indexed citations
4.
Peng, Yang, Di Wen, Feng Lin, & Ram I. Mahato. (2018). Co-delivery of siAlox15 and sunitinib for reversing the new-onset of type 1 diabetes in non-obese diabetic mice. Journal of Controlled Release. 292. 1–12. 14 indexed citations
5.
Lin, Feng, Xiaozhe Yang, Yanfeng Shi, et al.. (2018). Co-exposure subacute toxicity of silica nanoparticles and lead acetate on cardiovascular system. International Journal of Nanomedicine. Volume 13. 7819–7834. 33 indexed citations
6.
Xie, Jing, et al.. (2018). Serum human epididymis protein 4 is a predictor for developing nephritis in patients with systemic lupus erythematosus: A prospective cohort study. International Immunopharmacology. 60. 189–193. 18 indexed citations
7.
Lin, Feng, et al.. (2015). The overexpression of MRP4 is related to multidrug resistance in osteosarcoma cells. Journal of Cancer Research and Therapeutics. 11(1). 18–18. 23 indexed citations
8.
Yu, Wenxi, Lina Tang, Feng Lin, Yang Yao, & Zan Shen. (2015). Accuracy of Tokuhashi score system in predicting survival of lung cancer patients with vertebral metastasis. Journal of Neuro-Oncology. 125(2). 427–433. 9 indexed citations
9.
Shen, Dong, Weidong Mao, Tao Liu, et al.. (2014). Sedentary Behavior and Incident Cancer: A Meta-Analysis of Prospective Studies. PLoS ONE. 9(8). e105709–e105709. 100 indexed citations
11.
Qi, Wei‐Xiang, Lina Tang, Yaping Sun, et al.. (2013). Incidence and risk of hemorrhagic events with vascular endothelial growth factor receptor tyrosine-kinase inhibitors: an up-to-date meta-analysis of 27 randomized controlled trials. Annals of Oncology. 24(12). 2943–2952. 37 indexed citations
12.
Qi, Wei‐Xiang, Qiong Wang, Yanling Jiang, et al.. (2013). Overall Survival Benefits for Combining Targeted Therapy as Second-Line Treatment for Advanced Non-Small-Cell-Lung Cancer: A Meta-Analysis of Published Data. PLoS ONE. 8(2). e55637–e55637. 28 indexed citations
13.
Qi, Wei‐Xiang, Feng Lin, Aina He, et al.. (2013). Incidence and risk of denosumab-related hypocalcemia in cancer patients: a systematic review and pooled analysis of randomized controlled studies. Current Medical Research and Opinion. 29(9). 1067–1073. 39 indexed citations
16.
Qi, Wei‐Xiang, Lina Tang, Aina He, et al.. (2012). Erlotinib and pemetrexed as maintenance therapy for advanced non-small-cell lung cancer: a systematic review and indirect comparison. Current Medical Research and Opinion. 28(4). 643–650. 9 indexed citations
17.
Lin, Qingfeng, Weidong Mao, Yongqian Shu, et al.. (2011). A cluster of specified microRNAs in peripheral blood as biomarkers for metastatic non-small-cell lung cancer by stem-loop RT-PCR. Journal of Cancer Research and Clinical Oncology. 138(1). 85–93. 67 indexed citations
18.
Lin, Feng, Shuier Zheng, Zan Shen, et al.. (2010). Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma. Medical Oncology. 28(2). 649–653. 44 indexed citations
19.
Lin, Feng, et al.. (2009). Survival analysis of 71 cases of osteosarcoma with lung metastases. Tumori. 29(5). 471–474. 1 indexed citations
20.
Lin, Feng, Aiping Zeng, En Yang, et al.. (2007). Quantification of human bocavirus in lower respiratory tract infections in China. Infectious Agents and Cancer. 2(1). 3–3. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026